CompoAtlas

Quantis Éleuthérocoque Fève des Marais Griffonia

Food supplement declared in France, declaration No 2021-12-601, decision dated 14 December 2021

Quantis Éleuthérocoque Fève des Marais Griffonia, from LPEV, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Eleutherococcus senticosus 1.2 ml per day, Griffonia simplicifolia 1.2 ml per day, Vicia faba 1.2 ml per day. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
LPEV
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
10 mL
Directions for use
5 mL 2 fois par jour à diluer dans un verre d'eau
Not recommended (according to the manufacturer)
Breastfeeding women, Congenital G6PD deficiency (favism), Pregnant women, Taking antidepressants

Declaration 180741, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Eleutherococcus senticosus (Rupr. et Maxim.) MaximRacineExtrait fluide aqueux1.2 ml
Griffonia simplicifolia (DC.) Baill.GraineExtrait fluide aqueux1.2 ml
Vicia faba L.FruitExtrait fluide aqueux1.2 ml

Additives

E422

Other ingredients

jus de citron

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Ne pas utiliser en cas de favisme. Déconseillé aux femmes enceintes et allaitantes. Déconseillé aux personnes sous traitement antidépresseur.Ne peut se substituer à une alimentation variée, équilibrée et à un mode de vie sain. Tenir hors de la portée des enfants. Ne pas dépasser les doses journalières recommandées. Une consommation excessive peut avoir des effets laxatifs.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Eleutherococcus senticosus (Rupr. et Maxim.) Maxim
    Read the warning, when it applies and the studies cited

    ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS

    Route of administration: Oral (ESCOP 2003; Bradley 1992)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.

    Contraindications

    Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).

    Sources cited by Health Canada (5)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
    • Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.

    Health Canada monograph dated 31 October 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Quantis Éleuthérocoque Fève des Marais Griffonia: composition and regulation”, https://compoatlas.com/en/supplements/products/180741-quantis-eleutherocoque-feve-des-marais-griffonia, updated 15 November 2026.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line